Delivery Order SPE2DB25D3306-SPE2DB25FUBNG
Award Date
4/28/25
Potential Completion Date
4/29/25
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $17,738.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Dupixent 300 mg/2 ml pens, with an ultimate completion date of April 23, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,818.18, is for the delivery of Dupixent 300 mg/2 ml pens. It is a firm fixed-price delivery order contract, with a completion date of January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to AmerisourceBergen Drug Corp. The $7,778.44 firm-fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pharmaceutical pens, with a completion date of April 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This IDC serves as the primary...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Dupixent 300 mg/2 ml pens. The $7,743.22 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
This federal contract award, valued at $4,886.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Dupixent 300 mg/2 ml pens, a medication used for the treatment of certain medical conditions. The contract is a firm fixed-price delivery order with an ultimate completion date of April 23, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $47,157.90 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of July 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a wide range of...
This federal contract award from the Defense Logistics Agency (DLA) is a Firm Fixed Price Delivery Order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pens. The award, valued at $18,157.04, has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $13,675.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a performance period extending through April 29, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,988.82, is for the delivery of Dupixent 200 mg/1.14 ml pens. This is a firm fixed-price delivery order contract with an ultimate completion date of April 4, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,099.38, is for the delivery of Dupixent 300 mg/2 ml pens. This is a firm fixed-price delivery order contract with an ultimate completion date of April 14, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...